Tango Therapeutics, Inc. (TNGX) is a publicly traded Healthcare sector company. As of July 26, 2026, TNGX trades at $26.63 with a market cap of $4.34B and a P/E ratio of -30.59. TNGX moved -3.02% today. Year to date, TNGX is +200.56%; over the trailing twelve months it is +294.52%. Its 52-week range spans $1.03 to $34.39. Analyst consensus is strong buy with an average price target of $42.67. Rallies surfaces TNGX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
12 analysts cover TNGX: 0 strong buy, 11 buy, 1 hold, 0 sell, and 0 strong sell. The consensus rating is strong buy. The average price target is $42.67.
| Metric | Value |
|---|---|
| Price | $26.63 |
| Market Cap | $4.34B |
| P/E Ratio | -30.59 |
| EPS | $-0.87 |
| Dividend Yield | 0.00% |
| 52-Week High | $34.39 |
| 52-Week Low | $1.03 |
| Volume | 0 |
| Avg Volume | 0 |
| Revenue (TTM) | $62.38M |
| Net Income | $-101.59M |
| Gross Margin | 0.00% |
12 analysts cover TNGX: 0 strong buy, 11 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $42.67.